111 related articles for article (PubMed ID: 19189666)
1. p53, p16 and Fhit proteins expressions in chronic esophagitis and Chagas disease.
Bellini MF; Leite KR; Cury PM; Silva AE
Anticancer Res; 2008; 28(6A):3793-9. PubMed ID: 19189666
[TBL] [Abstract][Full Text] [Related]
2. Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis.
Kitamura A; Yashima K; Okamoto E; Andachi H; Hosoda A; Kishimoto Y; Shiota G; Ito H; Kaibara N; Kawasaki H
Oncology; 2001; 61(3):205-11. PubMed ID: 11574776
[TBL] [Abstract][Full Text] [Related]
3. Gene mutations in esophageal mucosa of chagas disease patients.
DA Silva Manoel-Caetano F; Silveira AF; Silva AE
Anticancer Res; 2009 Apr; 29(4):1243-7. PubMed ID: 19414370
[TBL] [Abstract][Full Text] [Related]
4. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.
Kawakubo H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2005 Dec; 14(6):1453-9. PubMed ID: 16273238
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area.
Guo XQ; Wang SJ; Zhang LW; Wang XL; Zhang JH; Guo W
J Exp Clin Cancer Res; 2007 Dec; 26(4):587-94. PubMed ID: 18365557
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
7. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
8. Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma.
Silveira AP; Da Silva Manoel-Caetano F; Aoki S; Yamasaki LH; Rahal P; Silva AE
Anticancer Res; 2011 May; 31(5):1685-90. PubMed ID: 21617227
[TBL] [Abstract][Full Text] [Related]
9. Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms.
Yasugi A; Yashima K; Hara A; Koda M; Kawaguchi K; Harada K; Andachi H; Murawaki Y
Oncol Rep; 2008 Jan; 19(1):41-7. PubMed ID: 18097574
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity.
Angiero F; Berenzi A; Benetti A; Rossi E; Del Sordo R; Sidoni A; Stefani M; Dessy E
Anticancer Res; 2008; 28(5A):2535-9. PubMed ID: 19035275
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.
Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA
Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385
[TBL] [Abstract][Full Text] [Related]
14. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.
Sepulveda JL; Komissarova EV; Kongkarnka S; Friedman RA; Davison JM; Levy B; Bryk D; Jobanputra V; Del Portillo A; Falk GW; Sonett JR; Lightdale CJ; Abrams JA; Wang TC; Sepulveda AR
Int J Cancer; 2019 Nov; 145(10):2754-2766. PubMed ID: 31001805
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p53 and FHIT in advanced oropharyngeal carcinoma.
Otero-Garcia JE; Youssef E; Enamorado II; Du W; Yoo GH; Merati K; Kewson D; Lonardo F; Jacobs JR; Kim H
Am J Otolaryngol; 2004; 25(4):231-9. PubMed ID: 15239028
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of PTEN and FHIT in oral squamous cell carcinoma and their relations with cyclin D1].
Shen LJ; Xie SM; Yin C; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):79-82. PubMed ID: 15684005
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
[TBL] [Abstract][Full Text] [Related]
18. Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesis.
Morita M; Oyama T; Nakata S; Ono K; Sugaya M; Uramoto H; Yoshimatsu T; Hanagiri T; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(3B):2243-8. PubMed ID: 16821595
[TBL] [Abstract][Full Text] [Related]
19. Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia.
Hayashi A; Yashima K; Takeda Y; Sasaki S; Kawaguchi K; Harada K; Murawaki Y; Ito H
J Gastroenterol Hepatol; 2012 Nov; 27(11):1752-8. PubMed ID: 22742976
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):584-6. PubMed ID: 15897145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]